Insulet Corporation
PODD- Market
- SPX
- Sector:
- Healthcare
- Industry
- Medical Devices
About the company
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Global score detail
Breakdown of the 4 modules in the global score (Macro, Sector, Fundamental, Technical)
Current Price
$138.77
Period High
$354.88
Period Low
$126.40
Analyst Target
$167.17
20.5% upside
Price history
Loading chart...
InvestCompass provides analysis tools, not financial advice. Data may be delayed.